Ceria-based nanotheranostic agent for rheumatoid arthritis
Irina Kalashnikova, Seock‐Jin Chung, Md Nafiujjaman, Meghan Hill, Mzingaye E. Siziba, Christopher H. Contag, Taeho Kim
Abstract
The inflammation-targeting, inherent contrast and therapeutic activity of this new albumin-cerium oxide nanoparticle may make it a relevant agent for assessing severity in RA, and other inflammatory diseases, and controlling inflammation with image-guidance. The design of these nanotheranostics will enable potential clinical translation as systemic therapy for RA.
Topics & Concepts
Rheumatoid arthritisMedicineComputer scienceImmunologyAdvanced Nanomaterials in CatalysisExtracellular vesicles in diseaseNanoplatforms for cancer theranostics